医学临床研究杂志

期刊简介

               《医学临床研究》由湖南省卫生厅主管、湖南省医学会主办,经国家新闻出版总署批准(中国连续出版物号ISSN1671-7171,CN43-1382/R)的医学临床类科技期刊。原名《湖南医学》,1984年10月创刊,由我国著名医学专家柳用墨教授任主编,1985年2月正式出版发行,2002年更名为《医学临床研究》由双月刊改为月刊。20多年来,本刊先后获得国家、省级一级一类优秀科技期刊奖多项,2000年入选中国期刊方阵(双效期刊),2002年4月再进入科技部中国科技论文统计源期刊,入编《中国学术期刊光盘版》,被万方数据库全文收录。本刊的宗旨是:注重学术,讲求质量,力创精品,为医学临床事业和广大科技工作者服务。设有论著、临床研究(含药物与临床、检验与临床、医学影像、麻醉等)、诊疗经验、护理园地、病例报告、医院管理等常规栏目,间有院士(专家)论坛、院长笔谈、述评及专题论述等特色栏目。目前稿源已涉及全国各省、市(区)及香港特区。  《医学临床研究》为月刊,每月26日出版,大16开本,192页,铜板纸印刷,每期定价15.00元,全年12期,国内外公开发行,邮发代号42-13,全国各地邮局均可订阅,编辑部亦可办理邮购。邮局汇款:湖南省长沙市湘雅路30号(省卫生厅内)医学临床研究杂志社,邮编410008。银行汇款:开户名称:医学临床研究杂志社开户银行:中国银行长沙市湘雅支行开户账号:610657349900Email:jcr_cs.hn@vip.163.com网址: http://www.jcr.net.cn联系电话(传真):0731-84824007。                

SCI论文投稿全程模板实例

时间:2024-03-22 09:31:25

SCI论文投稿全程模板主要包括以下几个部分:投稿信(Cover Letter)、论文正文、作者信息和致谢等。下面将详细介绍这些部分,并给出实例说明。

一、投稿信(Cover Letter)

投稿信是向编辑介绍论文内容和作者情况的重要文件,也是论文投稿过程中必不可少的一部分。在投稿信中,作者需要简要介绍论文的研究背景、目的、方法、结果和结论,同时说明论文的创新性和重要性。此外,作者还需要提供自己的联系方式和作者简介等信息。

以下是一个投稿信的实例:

Dear Editor,

We are pleased to submit our manuscript entitled "XXX" for consideration for publication in your journal. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.

We believe that our study is of great interest to the readers of your journal and will contribute significantly to the field of XXX research. We have carefully checked the manuscript for typographical and grammatical errors, and have ensured that the data presented are accurate and reproducible.

Please find attached the manuscript files in Word and PDF formats, as well as the figures and tables in separate files. We have also included a list of potential reviewers for your consideration. However, we would like to note that we have no conflicts of interest with any of the reviewers listed.

Thank you for considering our manuscript for publication in your journal. We look forward to hearing from you soon.

Sincerely,

[Your Name]
[Your Affiliation]
[Your Email Address]

二、论文正文

论文正文是SCI论文投稿的核心部分,包括标题、摘要、关键词、引言、方法、结果、讨论和结论等部分。在撰写论文正文时,作者需要遵循学术规范和论文写作要求,确保论文内容准确、清晰、有条理。

以下是一个论文正文的实例(仅包含部分部分):

Title: The effect of XXX on XXX in a mouse model of XXX

Abstract: In this study, we investigated the effect of XXX on XXX in a mouse model of XXX. We found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in mice. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX.

Keywords: XXX; XXX; Mouse model; Therapeutic agent

Introduction: XXX is a common disease that affects millions of people worldwide. Current treatments for XXX are limited and often associated with side effects. Therefore, there is an urgent need to develop new therapeutic agents for the treatment of XXX. In this study, we aimed to investigate the effect of XXX on XXX in a mouse model of XXX.

Methods: We used a mouse model of XXX to investigate the effect of XXX on XXX. Mice were randomly divided into two groups: a control group and a treatment group. The treatment group received XXX at a dose of XXX mg/kg/day for XXX days. All mice were sacrificed at the end of the experiment, and the levels of XXX were measured using XXX assay.

Results: We found that the levels of XXX were significantly reduced in the treatment group compared to the control group (Figure 1). In addition, the symptoms of XXX were also improved in the treatment group (Table 1).

Discussion: Our findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX. The reduction in the levels of XXX and improvement in the symptoms of XXX observed in our study are consistent with previous reports suggesting that XXX has anti-inflammatory and antioxidant properties. However, further studies are needed to confirm the efficacy and safety of XXX in humans.

Conclusion: In conclusion, we found that XXX significantly reduced the levels of XXX and improved the symptoms of XXX in a mouse model of XXX. These findings suggest that XXX may be a potential therapeutic agent for the treatment of XXX and warrant further investigation in clinical trials.

(注:以上实例中的XXX需要根据实际情况进行替换。)

三、作者信息和致谢

在论文正文的最后,作者需要提供详细的作者信息和致谢。作者信息包括作者的姓名、单位、联系方式等;致谢则是对在论文撰写过程中给予帮助和支持的人或机构表示感谢。

以下是一个作者信息和致谢的实例:

Authors: [Your Name], [Co-author's Name], [Another Co-author's Name]
Affiliations: [Your Affiliation], [Co-author's Affiliation], [Another Co-author's Affiliation]
Contact Information: [Your Email Address], [Your Phone Number]

Acknowledgments: We would like to thank [Name of Funding Agency] for providing financial support for this study. We also thank [Name of Individual] for their assistance with data collection and analysis. Finally, we would like to express our gratitude to the anonymous reviewers for their valuable comments and suggestions on the manuscript.